Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous sulphate versus CosmoFer for iron deficiency anaemia in adolescents with inflammatory bowel disease
2010-023797-39Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ferrous sulfate and iron sucrose in iron deficiency anemia (IDA), inflammatory bowel disease (IBD) and autoimmune colitis (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Mean increase in haemoglobin after 6 weeks of treatment. Started Jul 2011; status: completed.
02
Drugs
ferrous sulfateiron sucrose
03
Conditions
iron deficiency anemia (IDA)inflammatory bowel disease (IBD)autoimmune colitis
Beyond the preview
Go deeper on 2010-023797-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023797-39.